These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 27287718)

  • 1. (Z)-3,5,4'-Trimethoxystilbene Limits Hepatitis C and Cancer Pathophysiology by Blocking Microtubule Dynamics and Cell-Cycle Progression.
    Nguyen CB; Kotturi H; Waris G; Mohammed A; Chandrakesan P; May R; Sureban S; Weygant N; Qu D; Rao CV; Dhanasekaran DN; Bronze MS; Houchen CW; Ali N
    Cancer Res; 2016 Aug; 76(16):4887-96. PubMed ID: 27287718
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Fluvastatin interferes with hepatitis C virus replication via microtubule bundling and a doublecortin-like kinase-mediated mechanism.
    Ali N; Allam H; Bader T; May R; Basalingappa KM; Berry WL; Chandrakesan P; Qu D; Weygant N; Bronze MS; Umar S; Janknecht R; Sureban SM; Huycke M; Houchen CW
    PLoS One; 2013; 8(11):e80304. PubMed ID: 24260365
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Structural modification of resveratrol leads to increased anti-tumor activity, but causes profound changes in the mode of action.
    Scherzberg MC; Kiehl A; Zivkovic A; Stark H; Stein J; Fürst R; Steinhilber D; Ulrich-Rückert S
    Toxicol Appl Pharmacol; 2015 Aug; 287(1):67-76. PubMed ID: 26044878
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inflammatory and oncogenic roles of a tumor stem cell marker doublecortin-like kinase (DCLK1) in virus-induced chronic liver diseases.
    Ali N; Chandrakesan P; Nguyen CB; Husain S; Gillaspy AF; Huycke M; Berry WL; May R; Qu D; Weygant N; Sureban SM; Bronze MS; Dhanasekaran DN; Houchen CW
    Oncotarget; 2015 Aug; 6(24):20327-44. PubMed ID: 25948779
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Promotion of Cancer Stem-Like Cell Properties in Hepatitis C Virus-Infected Hepatocytes.
    Kwon YC; Bose SK; Steele R; Meyer K; Di Bisceglie AM; Ray RB; Ray R
    J Virol; 2015 Nov; 89(22):11549-56. PubMed ID: 26355082
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Resveratrol mediated cell death in cigarette smoke transformed breast epithelial cells is through induction of p21Waf1/Cip1 and inhibition of long patch base excision repair pathway.
    Mohapatra P; Satapathy SR; Das D; Siddharth S; Choudhuri T; Kundu CN
    Toxicol Appl Pharmacol; 2014 Mar; 275(3):221-31. PubMed ID: 24467951
    [TBL] [Abstract][Full Text] [Related]  

  • 7. ψ-Bufarenogin, a novel anti-tumor compound, suppresses liver cancer growth by inhibiting receptor tyrosine kinase-mediated signaling.
    Ding J; Wen W; Xiang D; Yin P; Liu Y; Liu C; He G; Cheng Z; Yin J; Sheng C; Zhang W; Nan F; Ye W; Zhang X; Wang H
    Oncotarget; 2015 May; 6(13):11627-39. PubMed ID: 25890498
    [TBL] [Abstract][Full Text] [Related]  

  • 8. YSL-12, a novel microtubule-destabilizing agent, exerts potent anti-tumor activity against colon cancer in vitro and in vivo.
    Cai D; Qiu Z; Yao W; Liu Y; Huang H; Liao S; Luo Q; Xie L; Lin Z
    Cancer Chemother Pharmacol; 2016 Jun; 77(6):1217-29. PubMed ID: 27107592
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Sinomenine hydrochloride inhibits human hepatocellular carcinoma cell growth in vitro and in vivo: involvement of cell cycle arrest and apoptosis induction.
    Lu XL; Zeng J; Chen YL; He PM; Wen MX; Ren MD; Hu YN; Lu GF; He SΧ
    Int J Oncol; 2013 Jan; 42(1):229-38. PubMed ID: 23165705
    [TBL] [Abstract][Full Text] [Related]  

  • 10. COH-203, a novel microtubule inhibitor, exhibits potent anti-tumor activity via p53-dependent senescence in hepatocellular carcinoma.
    Qi H; Zuo DY; Bai ZS; Xu JW; Li ZQ; Shen QR; Wang ZW; Zhang WG; Wu YL
    Biochem Biophys Res Commun; 2014 Dec; 455(3-4):262-8. PubMed ID: 25449279
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparative study of the effects of PEGylated interferon-α2a versus 5-fluorouracil on cancer stem cells in a rat model of hepatocellular carcinoma.
    Motawi TK; El-Boghdady NA; El-Sayed AM; Helmy HS
    Tumour Biol; 2016 Feb; 37(2):1617-25. PubMed ID: 26304505
    [TBL] [Abstract][Full Text] [Related]  

  • 12. XN05, a novel synthesized microtubule inhibitor, exhibits potent activity against human carcinoma cells in vitro.
    Wu R; Ding W; Liu T; Zhu H; Hu Y; Yang B; He Q
    Cancer Lett; 2009 Nov; 285(1):13-22. PubMed ID: 19647933
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Combretastatin A-1 phosphate, a microtubule inhibitor, acts on both hepatocellular carcinoma cells and tumor-associated macrophages by inhibiting the Wnt/β-catenin pathway.
    Mao J; Wang D; Wang Z; Tian W; Li X; Duan J; Wang Y; Yang H; You L; Cheng Y; Bian J; Chen Z; Yang Y
    Cancer Lett; 2016 Sep; 380(1):134-43. PubMed ID: 27349166
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Tivantinib induces G2/M arrest and apoptosis by disrupting tubulin polymerization in hepatocellular carcinoma.
    Xiang Q; Zhen Z; Deng DY; Wang J; Chen Y; Li J; Zhang Y; Wang F; Chen N; Chen H; Chen Y
    J Exp Clin Cancer Res; 2015 Oct; 34():118. PubMed ID: 26458953
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Novel phyto-derivative BRM270 inhibits hepatocellular carcinoma cells proliferation by inducing G2/M phase cell cycle arrest and apoptosis in xenograft mice model.
    Kumar Mongre R; Sharma N; Singh Sodhi S; Ghosh M; Kumar Singh A; Kim N; Park YH; Shin YG; Kim SJ; Jiao Jiao Z; Huynh DL; Jeong DK
    Biomed Pharmacother; 2017 Mar; 87():741-754. PubMed ID: 28110264
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Circulating tumor and cancer stem cells in hepatitis C virus-associated liver disease.
    Bahnassy AA; Zekri AR; El-Bastawisy A; Fawzy A; Shetta M; Hussein N; Omran D; Ahmed AA; El-Labbody SS
    World J Gastroenterol; 2014 Dec; 20(48):18240-8. PubMed ID: 25561791
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Steatohepatitic hepatocellular carcinoma (SH-HCC): a distinctive histological variant of HCC in hepatitis C virus-related cirrhosis with associated NAFLD/NASH.
    Salomao M; Yu WM; Brown RS; Emond JC; Lefkowitch JH
    Am J Surg Pathol; 2010 Nov; 34(11):1630-6. PubMed ID: 20975341
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Sustained antitumor activity by co-targeting mTOR and the microtubule with temsirolimus/vinblastine combination in hepatocellular carcinoma.
    Zhou Q; Lui VW; Lau CP; Cheng SH; Ng MH; Cai Y; Chan SL; Yeo W
    Biochem Pharmacol; 2012 May; 83(9):1146-58. PubMed ID: 22285225
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Amantadine inhibits cellular proliferation and induces the apoptosis of hepatocellular cancer cells in vitro.
    Lan Z; Chong Z; Liu C; Feng D; Fang D; Zang W; Zhou J
    Int J Mol Med; 2015 Sep; 36(3):904-10. PubMed ID: 26201988
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Tyr1068-phosphorylated epidermal growth factor receptor (EGFR) predicts cancer stem cell targeting by erlotinib in preclinical models of wild-type EGFR lung cancer.
    Sette G; Salvati V; Mottolese M; Visca P; Gallo E; Fecchi K; Pilozzi E; Duranti E; Policicchio E; Tartaglia M; Milella M; De Maria R; Eramo A
    Cell Death Dis; 2015 Aug; 6(8):e1850. PubMed ID: 26247735
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.